Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-20

Clinical Trial Update: Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether dexmedetomidine improves prognosis in elderly patients with postoperative cognitive dysfunction and delirium ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Postoperative Cognitive Dysfunction, Postoperative Delirium | Phase 4 | Status: COMPLETED